Predicting postoperative complications with artificial intelligence

Using artificial intelligence to predict postoperative complications in orthopaedic surgery can help clinical teams identify recovery risks earlier. Rather than judging risk from one observation, algorithms combine vital signs, medicines, laboratory results, procedure details and routine notes held in electronic health records. The aim is to support earlier review without replacing clinical judgement.

These events are not interchangeable. Infection, wound breakdown, delirium, falls, venous thromboembolism and readmission have different causes, warning signs and time scales. A model trained around the first 48 hours may perform poorly for a complication emerging weeks after discharge, so the prediction window and outcome must be defined precisely.

Australian use adds important differences. Queensland Health provides public hospital treatment under Medicare, often after long elective waiting lists, while private health insurance supports many procedures in private hospitals. Referral pathways, length of stay and documentation can differ sharply between these settings. A model that works only in a major metropolitan hospital may therefore miss the needs of patients treated elsewhere.

The goal is equitable use, not a technically impressive score. Aboriginal and Torres Strait Islander patients, people with limited English and residents of regional and remote areas must not face greater risk because a system was built on incomplete data. Cultural safety, patient consent, accessibility and local follow-up capacity belong in the design from the beginning.

From operating theatre to usable data

Routine records contain the first building blocks. Nurses record observations and mobility, pharmacists check medicines, surgeons document the operation, and physiotherapy teams note strength and function. These fragments often reveal a change before it appears in a formal assessment. Time matters: repeatedly changing observations may carry more signal than one unusual reading.

Preparation also determines whether a model is trustworthy. A record may describe a patient who was already flagged as high risk, allowing the system to learn from decisions as well as outcomes. Missing entries can reflect unequal access to staff or equipment. Developers must separate useful prediction from the replay of existing clinical patterns.

What artificial intelligence can estimate

Clinical questions determine the appropriate method. Logistic regression can provide a transparent baseline; machine-learning methods can capture interactions among age, frailty, medicines, laboratory values and procedural complexity. Each can estimate the probability of a defined event within a chosen period. None can remove uncertainty, and a probability needs context before it can support a decision.

Performance must be assessed beyond the hospital where a model was developed. Validation across different hospitals, teams and patient groups tests whether its estimates travel well. Calibration matters as much as discrimination: a predicted 20% risk should occur in roughly one of five comparable cases. Prospective monitoring should also reveal whether scores remain reliable as clinical practice changes.

Why Queensland care settings matter

Prediction begins with the care pathway, not the algorithm. Public patients may wait months for a hip replacement and then attend a short-stay pathway, while private patients may undergo elective surgery in a different setting. Emergency operations create another profile. Teams should compare where patients were assessed, admitted and treated, rather than pooling every record under the label of orthopaedic surgery.

Geography changes recovery after discharge. A patient returning to Townsville or Cairns may have fewer local review options than someone in Brisbane, with travel time affecting wound checks, physio and medicine supply. Models can help target outreach, but a high-risk flag cannot solve a service gap. Any pilot should include regional clinicians and community partners in deciding what support can realistically follow a prediction.

Moving risk scores into clinical decisions

A useful score changes what happens next. A higher risk of delirium might prompt closer overnight observation, a medication review and earlier involvement of family; a wound concern might trigger a prompt clinical review and, with consent, a photograph for the treating team. These responses should be linked to evidence and agreed thresholds. Automatically ordering tests or altering medicines without clinical review could create harm and waste.

Implementation also needs protection from alert fatigue. A busy ward should not receive a stream of predictions without an owner, a timeframe and a reason for acting. Clinicians need to see which information drove the estimate, alongside missing data and uncertainty. Silent evaluation can test the clinical workflow without distracting staff, followed by a limited pilot that tracks decisions as well as outcomes.

Communicating uncertainty with patients and families

Patients need information they can use without being overwhelmed by percentages. Clinicians can explain what is being estimated, what might change the estimate and which steps will follow. Australian patients may call the specialist “ortho” and the period after surgery “post-op”, but plain language still matters. Interpreters, accessible formats and communication support should be available whenever an individual needs them.

Aftercare instructions should extend beyond the discharge summary. The communication challenge is familiar beyond hospitals: community providers such as Waco County Dental show how practical advice can accompany clinical care. Orthopaedic teams can adapt that principle by giving patients and carers clear instructions about wound signs, activity, pain relief and whom to contact, written at an appropriate reading level.

Building skills and shared governance

Success depends on more than data science. Surgeons, anaesthetists, nurses, pharmacists, physiotherapists, general practitioners and consumers should help define useful warnings and acceptable responses. Researchers also need training in public engagement training so that findings do not stay inside research teams. Communicating uncertainty is as important as communicating technical performance.

Shared governance provides a practical route across institutions and sectors. Health services, universities and research institutes can agree on data standards, escalation protocols and ethics oversight before deployment. Collaboration with Aboriginal and Torres Strait Islander health organisations should accompany that work. Consumer representatives should review alerts, patient materials and the consequences of being labelled high risk.

Measuring benefit before routine use

A credible evaluation follows stages. First, retrospective testing establishes whether the model can predict outcomes in the intended population. Next, prospective testing checks calibration in live care and whether staff act appropriately. Through Brisbane Diamantina Health Partners, Queensland health services and researchers can coordinate the final assessment of patient benefit: fewer infections, readmissions or unplanned procedures, alongside better mobility and less distress for families.

Benefits must be weighed against burdens. Additional monitoring can occupy staff time, raise anxiety and expose patients to complications that might otherwise have resolved. Models should be rechecked after updates to records, medication formularies or surgical practice. Independent monitoring, clear responsibility for data quality and a process for withdrawing an unreliable tool are essential safeguards, not optional extras.

The move from a promising model to safer recovery is a shared undertaking. Queensland teams can begin by selecting one common complication, agreeing on a clear prediction window and reviewing local data with clinical and community partners. A small, prospective pilot with predefined safety measures can generate more useful evidence than a broad rollout based only on retrospective accuracy.

Clinicians, researchers, health services and consumers should now establish a cross-disciplinary group to define the first pilot, publish its measures and invite patients, families and carers into its governance. With responsible validation, transparent communication and a funded response pathway, artificial intelligence can become a practical aid for orthopaedic recovery across Queensland.